KINGSNORTH MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: G82730 | ASHFORD, TN23 3ED
Showing results 101-150 of 573
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Venlafaxine | 320 | 16.1K | £2.3K | -62.1% ▼ |
| Betamethasone valerate | 312 | 23.5K | £2.0K | -19.0% ▼ |
| Clarithromycin | 309 | 7,189 | £1.5K | +25.9% ▲ |
| Warfarin sodium | 307 | 18.9K | £656 | -34.9% ▼ |
| Spironolactone | 306 | 13.6K | £882 | -43.2% ▼ |
| Famotidine | 297 | 16.2K | £10.3K | -39.1% ▼ |
| Irbesartan | 297 | 16.4K | £709 | +21.9% ▲ |
| Dexamethasone | 293 | 1,655 | £1.0K | +70.4% ▲ |
| Lactulose | 287 | 148.7K | £1.4K | -12.8% ▼ |
| Mesalazine (Systemic) | 281 | 36.7K | £19.9K | +17.3% ▲ |
| Pantoprazole | 275 | 16.0K | £745 | +0.0% vs avg |
| 258 | 263 | £1.5K | +9.2% ▲ | |
| Bumetanide | 257 | 18.1K | £1.7K | -5.7% ▼ |
| Alogliptin | 257 | 13.0K | £11.8K | +1.3% vs avg |
| Methotrexate | 252 | 5,790 | £4.7K | -22.6% ▼ |
| Finasteride | 251 | 12.4K | £436 | -61.7% ▼ |
| Carbamazepine | 250 | 32.4K | £1.8K | -15.8% ▼ |
| Mirabegron | 249 | 11.0K | £10.1K | -38.0% ▼ |
| Tiotropium bromide | 244 | 4,014 | £8.2K | -19.7% ▼ |
| 241 | 319 | £14.1K | -22.4% ▼ | |
| 238 | 121.9K | £1.8K | -9.8% ▼ | |
| Rivaroxaban | 237 | 11.3K | £7.4K | -61.3% ▼ |
| Lymecycline | 237 | 13.3K | £1.5K | +97.0% ▲ |
| Semaglutide | 235 | 7,493 | £23.3K | -2.4% ▼ |
| Hydroxychloroquine sulfate | 234 | 14.9K | £662 | +20.8% ▲ |
| Fusidic acid | 225 | 6,210 | £743 | +76.2% ▲ |
| Digoxin | 221 | 10.6K | £774 | -41.6% ▼ |
| Emollient bath and shower preparations | 221 | 88.2K | £1.4K | +251.8% ▲ |
| Fluticasone/umeclidinium/vilanterol | 217 | 256 | £10.8K | -7.4% ▼ |
| Ferrous fumarate | 213 | 21.7K | £724 | -70.6% ▼ |
| 209 | 34.1K | £1.1K | -56.0% ▼ | |
| Lercanidipine hydrochloride | 207 | 11.8K | £1.2K | -66.5% ▼ |
| Topiramate | 207 | 21.6K | £1.2K | +16.5% ▲ |
| Canagliflozin | 204 | 12.2K | £15.2K | +42.1% ▲ |
| Mebeverine hydrochloride | 200 | 17.5K | £701 | -35.6% ▼ |
| 200 | 200 | £627 | +680.9% ▲ | |
| Empagliflozin | 193 | 9,882 | £12.3K | -69.2% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 192 | 37.6K | £2.5K | -15.0% ▼ |
| Letrozole | 192 | 9,884 | £901 | +2.8% ▲ |
| Melatonin | 191 | 9,902 | £2.1K | -42.6% ▼ |
| Promethazine hydrochloride | 190 | 7,219 | £983 | -46.8% ▼ |
| Sodium valproate | 190 | 18.4K | £3.6K | -40.3% ▼ |
| Calcipotriol | 188 | 17.5K | £8.6K | +10.4% ▲ |
| Hyoscine butylbromide | 186 | 16.9K | £1.2K | -20.2% ▼ |
| Eplerenone | 186 | 8,344 | £1.0K | -29.9% ▼ |
| Betahistine hydrochloride | 185 | 18.7K | £614 | -22.5% ▼ |
| Gliclazide | 179 | 15.3K | £1.0K | -79.0% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 177 | 6,301 | £602 | +15.9% ▲ |
| Senna | 174 | 13.9K | £320 | -71.1% ▼ |
| Quinine sulfate | 173 | 8,050 | £1.1K | -40.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.